InvestorsHub Logo
Followers 2
Posts 374
Boards Moderated 0
Alias Born 02/06/2013

Re: None

Saturday, 11/30/2013 11:06:14 AM

Saturday, November 30, 2013 11:06:14 AM

Post# of 2191
$ZLCS Zalicus Inc announced that it has been granted a patent by the U.S. Patent and Trademark office (USPTO) covering its product candidate Z944. United States patent number 8,377,968 entitled N-Piperidinyl Acetamide Derivatives as Calcium Channel Blockers provides broad coverage for Z944 including compositions of matter and certain therapeutic methods of use through April 2029.